2015-08-17T10:22:32-05:00 2014-09-30 263753134 CBIZ TOFIAS 500 BOYLSTON STREET BOSTON MA 02116 990 2013-10-01 222984590 JOSLIN CLINIC INC JOSL 6172265730 ONE JOSLIN PLACE BOSTON MA 02215 ELIOT LURIER CHIEF FINANCIAL OFFICER 6172265730 2015-08-14 1 CRAIG KLEIN P00734640 6177610600 2015-08-10 2013 2016-03-07 17:11:31Z JOHN L BROOKS III ONE JOSLIN PLACE BOSTON MA 02215 26366064 0 X WWW.JOSLIN.ORG X 1984 MA PATIENT CARE 3 1 0 1 0 0 6254622 6985948 19524269 19380116 0 0 0 0 25778891 26366064 0 0 0 0 0 0 0 0 0 25778891 26366064 25778891 26366064 0 0 2659233 2313317 2659233 2313317 0 0 X PATIENT CARE 0 0 26366064 19380116 PATIENT CARE: JOSLIN CLINIC HAS TREATED PATIENTS IN ITS SEVENTEEN YEARS OF OPERATION. PATIENTS ARE TREATED ANNUALLY ON AN OUTPATIENT BASIS FOR SERVICES THAT INCLUDE ENDOCRINOLOGY, OPHTHALMOLOGY, NEPHROLOGY, PSYCHOSOCIAL SERVICES, NUTRITION, EXERCISE, PHYSIOLOGY AND OTHER. SEE THE COMMUNITY BENEFIT STATEMENT ON SCHEDULE O. 26366064 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 1 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MA X X BETH CADLE 6173095749 ONE JOSLIN PLACE BOSTON MA 02215 ROSS J MARKELLO CFO/TREASURER 1.00 39.00 X X 0 485212 42676 ANNE M LAGASSE TRUSTEE 1.00 2.00 X 0 0 0 JOHN L BROOKS III PRESIDENT/CEO 1.00 39.00 X X 0 681109 31479 ELIOT LURIER CHIEF FINANCIAL OFFICER 1.00 39.00 X X 0 0 0 MARIA BUCKLEY CLERK 1.00 39.00 X 0 271194 16126 MARTIN J ABRAHAMSON FORMER TRUSTEE/SR. VP, MED. AFFAIRS 1.00 39.00 X 0 310436 38676 0 1747951 128957 0 1 1 0 JOSLIN DIABETES CENTER INC ONE JOSLIN PLACE BOSTON MA 02215 MANAGEMENT SERVICES 19952104 1 6978115 7833 6985948 NET PATIENT CARE 621400 13753073 13753073 OFFSITE PATIENT CARE 900099 5627043 5627043 19380116 26366064 19380116 0 0 X 26366064 26366064 26366064 26366064 0 0 1307340 1641146 1351893 672171 2659233 2313317 603353 386243 2055880 1927074 2659233 2313317 X 0 0 2659233 2313317 0 0 X 0 1 X 1 0 X X X 0 0 0 JOSLIN DIABETES CENTER INC 042203836 7 1 1 1 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO JOSLIN DIABETES CENTER 1927074 1927074 X 26366064 0 26366064 0 26366064 26366064 0 26366064 0 26366064 PART X, LINE 2: JOSLIN, THE CLINIC, AND JOSLIN TECHNOLOGIES HAVE BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE (IRS) AS ORGANIZATIONS DESCRIBED IN INTERNAL REVENUE CODE (THE "CODE") SECTION 501(C)(3) AND, THEREFORE, ARE EXEMPT FROM TAXATION ON RELATED INCOME UNDER SECTION 501(A) OF THE CODE. THE IRS HAS ALSO PREVIOUSLY DETERMINED THAT THESE ENTITIES ARE NOT PRIVATE FOUNDATIONS PURSUANT TO SECTION 509(A) OF THE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS. THE CENTER RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED. CHANGES IN RECOGNITION IN MEASUREMENT ARE REFLECTED IN THE PERIOD IN WHICH THE CHANGE IN JUDGMENT OCCURS. THE CENTER DID NOT RECOGNIZE THE EFFECT OF ANY INCOME TAX POSITION IN EITHER 2014 OR 2013. 0 0 0 0 0 0 0 0 0 ROSS J MARKELLO CFO/TREASURER 0 483322 0 0 0 1890 0 19495 0 23181 0 527888 0 0 JOHN L BROOKS III PRESIDENT/CEO 0 679219 0 0 0 1890 0 3530 0 27949 0 712588 0 0 MARIA BUCKLEY CLERK 0 270444 0 0 0 750 0 0 0 16126 0 287320 0 0 MARTIN J ABRAHAMSON FORMER TRUSTEE/SR. VP, MED. AFFAIRS 0 308546 0 0 0 1890 0 19495 0 19181 0 349112 0 0 PART I, LINE 3: THE CLINIC'S TOP MANAGEMENT OFFICIAL AND TOP FINANCIAL OFFICIAL ARE COMPENSATED THROUGH ITS RELATED ORGANIZATION, JOSLIN DIABETES CENTER. THE FOLLOWING IS THE DISCLOSURE AS PRESENTED ON THE JOSLIN DIABETES CENTER'S FORM 990 REGARDING COMPENSATION FOR THE TOP OFFICERS AND THE CEO: EXECUTIVE COMPENSATION INCLUDES THE CEO AND THE SENIOR LEADERSHIP TEAM. PAY FOR THE CEO IS DETERMINED BY THE BOARD. THE HUMAN RESOURCE DEPARTMENT PROVIDES SURVEY DATA AS REQUESTED. SENIOR LEADERSHIP TEAM PAY IS DETERMINED BY THE CEO WITH SURVEY DATA PROVIDED BY HR. EXECUTIVE COMPENSATION IS REVIEWED ANNUALLY BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ALL CASES, COMPENSATION IS DETERMINED BY INDEPENDENT PERSONS. INDIVIDUALS ARE PROHIBITED FROM ACTIVE PARTICIPATION IN ANY DECISIONS REGARDING THEIR OWN COMPENSATION. FORM 990, PART III, LINE 4A: COMMUNITY BENEFIT STATEMENT JOSLIN CLINIC IS PART OF JOSLIN DIABETES CENTER, THE WORLD'S LARGEST DIABETES RESEARCH AND CLINICAL CARE ORGANIZATION. JOSLIN IS DEDICATED TO ENSURING THAT PEOPLE WITH DIABETES LIVE LONG, HEALTHY LIVES AND OFFERS REAL HOPE AND PROGRESS TOWARD DIABETES PREVENTION AND A CURE. JOSLIN IS AN INDEPENDENT, NONPROFIT INSTITUTION AFFILIATED WITH HARVARD MEDICAL SCHOOL. OUR MISSION IS TO PREVENT, TREAT AND CURE DIABETES. OUR VISION IS A WORLD FREE OF DIABETES AND ITS COMPLICATIONS. DIABETES IS A GLOBAL PANDEMIC DIABETES IS A DEVASTATING AND POTENTIALLY FATAL DISEASE THAT IS A GLOBAL PROBLEM. THE STATISTICS ARE SOBERING: THE NUMBER OF PEOPLE LIVING WITH DIABETES WILL INCREASE FROM 387 MILLION IN 2013 TO 592 MILLION IN 2035, ACCORDING TO THE 2014 INTERNATIONAL DIABETES FEDERATION (IDF) DIABETES ATLAS. FULLY HALF OF PEOPLE WITH TYPE 2 DIABETES DON'T KNOW THEY HAVE IT, SO THEY AREN'T SEEKING MEDICAL HELP TO MANAGE THEIR CONDITION AND PREVENT POTENTIALLY FATAL COMPLICATIONS. EVERY SEVEN SECONDS AROUND THE WORLD, SOMEONE DIES FROM DIABETES. DIABETES IN THE UNITED STATES - MORE THAN 29 MILLION AMERICANS ARE LIVING WITH DIABETES TODAY - BY 2050, AS MANY AS 1 IN 3 AMERICAN ADULTS WILL HAVE DIABETES IF PRESENT TRENDS CONTINUE - DIABETES KILLS MORE AMERICANS EVERY YEAR THAN AIDS AND BREAST CANCER COMBINED COMPARED TO THEIR COUNTERPARTS WITHOUT DIABETES, ADULTS WITH DIABETES IN THE U.S: - SPEND 2.3 TIMES MORE ON MEDICAL COSTS EACH YEAR - HAVE A 50% HIGHER RISK OF DEATH - ARE 1.8 TIMES MORE LIKELY TO BE HOSPITALIZED FOR HEART ATTACK, AND 1.7 TIMES MORE LIKELY TO DIE FROM CARDIOVASCULAR DISEASE THE PERSONAL AND FINANCIAL IMPACT OF DIABETES DIABETES IS ASSOCIATED WITH AN INCREASED RISK FOR A NUMBER OF DEVASTATING COMPLICATIONS, INCLUDING HEART DISEASE AND STROKE, KIDNEY DISEASE, BLINDNESS AND AMPUTATIONS. OVERALL, THE RISK FOR DEATH AMONG PEOPLE WITH DIABETES IS ABOUT TWICE THAT OF PEOPLE WITHOUT DIABETES OF SIMILAR AGE. INCREASES IN BOTH TYPES 1 AND 2 DIABETES, AS WELL AS OBESITY, A PRECURSOR OF TYPE 2 DIABETES, ARE ALSO BEING OBSERVED IN CHILDREN AND ADOLESCENTS, PRESENTING FUTURE CHALLENGES TO THE HEALTHCARE SYSTEM. IN ADDITION TO THE HUMAN TOLL, THE FINANCIAL BURDEN ASSOCIATED WITH DIABETES IS STAGGERING. ACCORDING TO THE AMERICAN DIABETES ASSOCIATION, THE TOTAL COST OF DIAGNOSED DIABETES IN THE U.S. IN 2012 WAS $245 BILLION - A 41% INCREASE OVER 2007. OF THAT $245 BILLION: - $176 BILLION (72% OF TOTAL COST) WAS DIRECT MEDICAL COST, INCLUDING HOSPITAL AND EMERGENCY CARE, OFFICE VISITS AND MEDICATION - $69 BILLION (28% OF TOTAL COSTS) WAS THE COST OF REDUCED AND LOST PRODUCTIVITY FROM ABSENTEEISM, UNEMPLOYMENT AND DEATH JOSLIN PATIENT CARE: LIVING LONG AND WELL WITH DIABETES JOSLIN HELPS ADULTS, ADOLESCENTS AND CHILDREN CHALLENGED WITH TYPE 1 AND TYPE 2 DIABETES TO LIVE LONG, HEALTHY LIVES, FREE OF COMPLICATIONS. ALL OF OUR PHYSICIANS, DIABETES EDUCATORS, AND SPECIALTY CLINICIANS ARE EXPERT IN ALL FACETS OF DIABETES. OUR CLINIC HAS THE HIGHEST CONCENTRATION OF CERTIFIED DIABETES EDUCATORS - NURSES, DIETITIANS, EXERCISE PHYSIOLOGISTS, NURSE PRACTITIONERS AND MENTAL HEALTH PROFESSIONALS - THAN ANYWHERE ELSE IN THE WORLD. OUR WORLD-RENOWNED ENDOCRINOLOGISTS, CERTIFIED DIABETES EDUCATORS, NUTRITIONISTS, EXERCISE PHYSIOLOGISTS AND OTHER CLINICAL SPECIALISTS PROVIDE: - PERSONALIZED CARE AND SUPPORT TO HELP PATIENTS AND THEIR FAMILIES MANAGE THEIR DIABETES - STATE-OF-THE-ART MEDICAL CARE, WITH EXPERTISE IN TECHNOLOGY (I.E., PUMPS, CONTINUOUS GLUCOSE MONITORS), NUTRITION, PHYSICAL ACTIVITY AND ALL 15 CLASSES OF DIABETES MEDICATIONS - AGGRESSIVE PREVENTION AND MANAGEMENT OF COMPLICATIONS BECAUSE OF OUR CLINIC'S SINGLE-MINDED FOCUS ON CUTTING-EDGE CARE, JOSLIN HAS EXCELLENT CLINICAL QUALITY CARE METRICS - OUTPERFORMING IN EVERY CATEGORY OF BOTH OUTCOME QUALITY MEASURES AND PROCESS QUALITY MEASURES: - JOSLIN OUTPERFORMS THE ADA BENCHMARK FOR ALL THREE OUTCOME QUALITY MEASURES - A1C, BLOOD PRESSURE AND CHOLESTEROL - JOSLIN OUTPERFORMS THE ADA BENCHMARK FOR ALL FIVE PROCESS QUALITY MEASURES - JOSLIN ACHIEVES THE HEDIS 90TH PERCENTILE GOAL IN ALL OF SIX OF THE POSSIBLE CATEGORIES. FORM 990, PART VI, SECTION A, LINE 3 PURSUANT TO A SERVICES AGREEMENT, JOSLIN DIABETES CENTER, INC. IS SUPERVISING, DIRECTING AND CONTROLLING THE DAY-TO-DAY BUSINESS ACTIVITIES, MANAGEMENT, ADMINISTRATION, AND OPERATION OF JOSLIN CLINIC, INC.'S BUSINESS AND ASSETS. JOSLIN CLINIC, INC. IS A SUPPORTING ORGANIZATION OF JOSLIN DIABETES CENTER, INC. FORM 990, PART VI, SECTION A, LINE 6 JOSLIN CLINIC, INC. HAS ONE CORPORATE MEMBER, JOSLIN DIABETES CENTER, INC. ("THE CENTER"). FORM 990, PART VI, SECTION A, LINE 7A JOSLIN CLINIC, INC. HAS ONE CORPORATE MEMBER, JOSLIN DIABETES CENTER, INC. ("THE CENTER"). FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY MEMBERS OF THE FISCAL SERVICES DEPARTMENT FOR COMPLETENESS AND ACCURACY. A COPY OF THE FORM AS IT WILL BE FILED WITH THE INTERNAL REVENUE SERVICE WILL BE E-MAILED TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE GENERAL COUNSEL'S OFFICE DISTRIBUTES AN ANNUAL DISCLOSURE FORM TO ALL OFFICERS, TRUSTEES AND EMPLOYEES ANNUALLY. THE INFORMATION DISCLOSED IS REVIEWED BY THE GENERAL COUNSEL AND, IF A POTENTIAL CONFLICT EXISTS, BY THE COMMITTEE AS DEFINED BELOW. THE DISCLOSURE FORMS OF THE VICE PRESIDENTS WILL BE REVIEWED BY THE GENERAL COUNSEL AND THE PRESIDENT, THE DISCLOSURE FORM OF THE PRESIDENT WILL BE BE REVIEWED BY THE GENERAL COUNSEL AND THE CHAIR OF THE BOARD. IF A POTENTIAL CONFLICT IS FOUND TO EXIST, THE INDIVIDUAL SHALL REFRAIN FROM ACTIVE PARTICIPATION IN ANY DECISION CONCERNING THE MATTER. FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 AND THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE FOR REVIEW AT THE FISCAL SERVICES OFFICE AND THE MASSACHUSETTS ATTORNEY GENERAL'S WEBSITE. THEY ARE ALSO AVAILABLE IN AN ELECTRONIC FORMAT UPON REQUEST. THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND THE WHISTLEBLOWER POLICY ARE AVAILABLE FOR REVIEW AT THE OFFICE OF THE GENERAL COUNSEL OR IN AN ELECTRONIC FORMAT UPON REQUEST. FORM 990, PART VI, SECTION B, LINE 15A & 15B: JOSLIN CLINIC DOES NOT DIRECTLY COMPENSATE ITS CEO OR ANY OF ITS OTHER OFFICERS. COMPENSATION FOR THESE INDIVIDUALS IS SET BY THE JOSLIN DIABETES CENTER ("THE CENTER") FOLLOWING THE PROCEDURES OF THE CENTER AS OUTLINED BELOW: EXECUTIVE COMPENSATION INCLUDES THE CEO AND THE SENIOR LEADERSHIP TEAM. PAY FOR THE CEO IS DETERMINED BY THE BOARD. THE HUMAN RESOURCE DEPARTMENT PROVIDES SURVEY DATA AS REQUESTED. SENIOR LEADERSHIP TEAM PAY IS DETERMINED BY THE CEO WITH SURVEY DATA PROVIDED BY HR. EXECUTIVE COMPENSATION IS REVIEWED ANNUALLY BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ALL CASES, COMPENSATION IS DETERMINED BY INDEPENDENT PERSONS. INDIVIDUALS ARE PROHIBITED FROM ACTIVE PARTICIPATION IN ANY DECISIONS REGARDING THEIR OWN COMPENSATION. FORM 990, PART VI, SECTION B: EXISTENCE OF POLICIES THE CONFLICT OF INTEREST POLICY, WHISTLEBLOWER POLICY AND DOCUMENT RETENTION POLICY FOR THE JOSLIN DIABETES CENTER ARE IN EFFECT FOR, AND GOVERN, THE JOSLIN CLINIC. REGULAR AND CONSISTENT MONITORING AND ENFORCEMENT OF COMPLIANCE WITH THESE POLICIES ARE MANAGED BY THE JOSLIN DIABETES CENTER. FORM 990, PART IX, LINE 11G PATIENT CARE AND MANAGEMENT SERVICES: PROGRAM SERVICE EXPENSES 19,952,104. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 19,952,104. SPACE LEASE COSTS: PROGRAM SERVICE EXPENSES 6,413,960. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 6,413,960. JOSLIN DIABETES CENTER INC ONE JOSLIN PLACE BOSTON MA 022155306 042203836 DIABETES RESEARCH FACILITY MA 501(C)(3) LINE 7 N/A 0 JOSLIN TECHNOLOGIES LLC ONE JOSLIN PLACE BOSTON MA 022155306 364695829 MEDICAL RESEARCH MA 501(C)(3) LINE 9 JOSLIN DIABETES CENTER INC 1 0 0 1 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0